Bioartificial bone grafting: Tarsal joint fusion in a dog using a bioartificial composite bone graft consisting of beta-tricalciumphosphate and platelet rich plasma -- A case report

Grafting of large bone defects caused by trauma or tumor resection still remains a problem to solve. In experimental studies as well as in human dentistry, osteoconduction and biodegradation of the beta-tricalciumphosphate Cerasorb as well as osteoinductive capabilities of platelet rich plasma have...

Full description

Saved in:
Bibliographic Details
Published inVeterinary and comparative orthopaedics and traumatology Vol. 18; no. 1; pp. 52 - 54
Main Authors Hauschild, G, Merten, H.A, Bader, A, Uhr, G, Deivick, A, Meyer-Lindenberg, A, Fehr, M
Format Journal Article
LanguageEnglish
Published Germany 2005
Subjects
Online AccessGet more information

Cover

Loading…
More Information
Summary:Grafting of large bone defects caused by trauma or tumor resection still remains a problem to solve. In experimental studies as well as in human dentistry, osteoconduction and biodegradation of the beta-tricalciumphosphate Cerasorb as well as osteoinductive capabilities of platelet rich plasma have been proven. In case of luxation of the right tarsal joint, including a compressive fracture of the forth tarsal bone, the recommended use of autologous cancellous bone to support osseous fusion was replaced by the use of a bioartificial bone graft. Biodegradation of the bone graft was proven clinically and radiographically. Complete osseous fusion of the intertarsal joint occurred. The use of the beta-tricalciumphosphate Cerasorb in combination with platelet rich plasma to support a partial arthrodesis of the tarsal joint in a dog did not impede the healing process but led to full recovery of the patient, indicating that this concept of bioartificial bone grafting could support bone healing.
ISSN:0932-0814
2567-6911
DOI:10.1055/s-0038-1632929